Carl-Emil Grøn Fuglesang Net Worth (Estimated)
Founder at Reshape Biotech · YC W21
Quick answer
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026.
Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech (YC W21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Master's degree in Biochemistry
- Region: Denmark
- Industries: Healthcare, Industrial Bio
- Team size: 40
- Website: http://reshapebiotech.com/
Who is Carl-Emil Grøn Fuglesang?
Carl-Emil Grøn Fuglesang is a co-founder of Reshape Biotech, a company participating in Y Combinator's Winter 2021 batch.
Highlights:
- University of Copenhagen
- Technical University of Denmark
- Y Combinator W21
About Reshape Biotech
Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images. Other companies try to sell “one lab robot that does everything”. But those robots become so complicated that they sit unused on the shelf. We build one robot for each function, which makes them easy to use.
Model inputs
- Stage: series-a
- Valuation tier: raise-10x
- Funding input: reported raise $20.0M
- Valuation note: First-party Series A matches leftover $20M. Lock that close.
- Research as-of: 2026-09-14
- Funding source: https://reshapebiotech.com/blog/we-have-raised-20m-in-our-series-a
FAQ: Carl-Emil Grøn Fuglesang net worth and Reshape Biotech valuation
What is Carl-Emil Grøn Fuglesang's net worth?
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Carl-Emil Grøn Fuglesang net worth
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. This Carl-Emil Grøn Fuglesang net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Carl-Emil Grøn Fuglesang worth?
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. How much Carl-Emil Grøn Fuglesang is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Carl-Emil Grøn Fuglesang?
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. “How rich is Carl-Emil Grøn Fuglesang” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Carl-Emil Grøn Fuglesang fortune
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. This Carl-Emil Grøn Fuglesang fortune figure is estimated paper wealth only, not a verified statement of assets.
Carl-Emil Grøn Fuglesang equity value
Carl-Emil Grøn Fuglesang's estimated net worth / paper wealth is $18.7M (range $13.1M–$28.0M) as of 2026. Carl-Emil Grøn Fuglesang equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Reshape Biotech valuation?
Reshape Biotech's estimated valuation on Entrepreneurial Check is $200.0M. Independent model output, not a verified appraisal or official mark.
What is Reshape Biotech post-money valuation?
Reshape Biotech's estimated valuation on Entrepreneurial Check is $200.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Reshape Biotech funding?
Reshape Biotech funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Reshape Biotech raised is not a complete cap table — figures are estimates only.
How much did Reshape Biotech raise?
How much Reshape Biotech raised, when disclosed, informs the estimated Reshape Biotech valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Reshape Biotech raise?
How much money Reshape Biotech raised, when a public figure is available, is a model input for the estimated Reshape Biotech valuation on this profile. Estimates only — not a complete cap table.
What is Reshape Biotech series funding?
Reshape Biotech series funding, when a public raise is disclosed, informs the estimated Reshape Biotech valuation here. Not a complete financing history.
What company is Carl-Emil Grøn Fuglesang building?
Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech, a Y Combinator-backed startup (batch W21).
What does Reshape Biotech do?
Reshape Biotech — Robots that automate the everyday tasks of microbiologists.
What YC batch is Carl-Emil Grøn Fuglesang from?
Carl-Emil Grøn Fuglesang is associated with Y Combinator batch W21.
Where did Carl-Emil Grøn Fuglesang go to school?
Public profiles associate Carl-Emil Grøn Fuglesang with Master's degree in Biochemistry.
Where is Carl-Emil Grøn Fuglesang based?
Public directory data lists Carl-Emil Grøn Fuglesang's region as Denmark.
What industry is Carl-Emil Grøn Fuglesang in?
Carl-Emil Grøn Fuglesang is listed under Healthcare, Industrial Bio.
How big is Reshape Biotech?
Public data lists Reshape Biotech's team size as 40.
What else is notable about Carl-Emil Grøn Fuglesang?
University of Copenhagen.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.